• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Nkx1-2

ErbB4 receptor tyrosine kinase contributes to the advancement of the center,

February 13, 2018 by Katherine Lewis Leave a Comment

ErbB4 receptor tyrosine kinase contributes to the advancement of the center, the central nervous program, and the lactating mammary gland, but whether a function is had by it in the advancement of the kidney epithelium is unidentified. and polarization, mobile features important for the advancement of epithelial ducts in the kidney. ErbB4 is certainly a … [Read more…]

Posted in: Blogging Tagged: AZD8055 IC50, Nkx1-2

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by